Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Caitlin E. Cox

December 31, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Caitlin E. Cox

August 13, 2025

News Daily News

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

L.A. McKeown

July 30, 2025

News Daily News

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

L.A. McKeown

February 24, 2025

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Yael L. Maxwell

December 06, 2022

News Daily News

New-Onset AF Not Uncommon After Mitral TEER

Todd Neale

September 13, 2022

News Daily News

DOACs Safe, Effective in Subset of Valvular AF Patients

Shelley Wood

March 31, 2021

News Daily News

Routine Anticoagulation Seems Warranted After TMVR: Review

Todd Neale

December 04, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Daily News

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

Todd Neale

March 12, 2019

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

L.A. McKeown

March 20, 2014

Advertisement

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

CVD Still the Leading Cause of Death and Disease Globally

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

New-Onset AF Not Uncommon After Mitral TEER

DOACs Safe, Effective in Subset of Valvular AF Patients

Routine Anticoagulation Seems Warranted After TMVR: Review

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content